Results of the MRC pilot study show autografting for younger patients with chronic lymphocytic leukemia is safe and achieves a high percentage of molecular responses. (2005)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood-2004-01-0298

PubMed Identifier: 15117764

Publication URI: http://europepmc.org/abstract/MED/15117764

Type: Journal Article/Review

Volume: 105

Parent Publication: Blood

Issue: 1

ISSN: 0006-4971